Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

DBV Technologies

DBV Technologies reported $-15297000 in EBITDA for its fiscal quarter ending in September of 2022.

Ebitda Change
Acadia Pharmaceuticals ACAD:US USD -53158000 7.58M
Alnylam Pharmaceuticals ALNY:US USD -135742000 38.56M
BioMarin Pharmaceutical BMRN:US USD 87.87M 87.82M
Esperion Therapeutics ESPR:US USD -48524000 6.1M
Halozyme Therapeutics HALO:US USD 74.26M 8.8M
Incyte Corp INCY:US USD 48.82M 62.76M
Insmed INSM:US USD -154469000 4.76M
Intercept Pharmaceuticals ICPT:US USD -31543000 13.66M
Ionis Pharmaceuticals IONS:US USD -110937000 93.44M
Neurocrine Biosciences NBIX:US USD 34.7M 73.1M
PTC Therapeutics PTCT:US USD -74790000 53.3M
Sarepta Therapeutics SRPT:US USD -126783000 30.5M
Ultragenyx Pharmaceutical RARE:US USD -148869000 8.2M
United Therapeutics UTHR:US USD 297.7M 97.7M